Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

Nature Genetics volume 9, pages 401–406 (1995)Cite this article

Abstract

Overexpression of amplified genes is often associated with the acquisition of resistance to cancer therapeutic agents in vitro. We have identified a similar molecular mechanism in vivo for endocrine treatment failure in human prostate cancer which involves amplification of the androgen receptor (AR) gene. Comparative genomic hybridization shows that amplification of the Xq11–q13 region (the location), is common in tumours recurring during androgen deprivation therapy. We found high–level AR amplification in seven of 23 (30%) recurrent tumours, but in none of the specimens taken from the same patients prior to therapy. Our results suggest that AR amplification emerges during androgen deprivation therapy by facilitating tumour cell growth in low androgen concentrations.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Article 04 February 2021

Richard J. Rebello, Christoph Oing, … Robert G. Bristow

References

  1. Boring, C.C., Squires, T.S. & Tong, T. Cancer Statistics, 1993 CA. Cancer J. Clin. 43, 7–26 (1993).

    Article  CAS  Google Scholar 

  2. Gittes, R.F. Carcinoma of the prostate. New Engl. J. Med. 324, 236–245 (1991).

    Article  CAS  Google Scholar 

  3. Stearn, M.E. & McGarvey, T. Biology of disease. Prostate cancer: therapeutics, diagnostic, and basic studies. Lab. Invest. 67, 540–552 (1992).

    Google Scholar 

  4. Berges, R.R., Furuya, Y., Remington, L., English, H.F., Jacks, T. .& Isaacs, J.T. Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. Proc. natn. Acad. Sci. U.S.A. 90, 8910–8914 (1993).

    Article  CAS  Google Scholar 

  5. Labrie, F., Belanger, A., Dupont, A., Luu-The, V., Simard, J. & Labrie, C. Science behind total androgen blockade: from gene to combination therapy. Clin. Invest. Med. 16, 475–492 (1993).

    CAS  PubMed  Google Scholar 

  6. Culig, Z. et al. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Molec. Endocrinol. 7, 1541–1550 (1993).

    CAS  Google Scholar 

  7. Schoenberg, M.P. et al. Microsatelllte mutation (CAG24–18) in the androgen receptor gene In human prostate cancer. Biochem. Biophys. Res. Comm. 198, 74–80 (1994).

    Article  CAS  Google Scholar 

  8. Veldscholte, J. et al. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem. Biophys. Res. Commun. 173, 534–540 (1990).

    Article  CAS  Google Scholar 

  9. Thompson, T.C. Growth factors and oncogenes in prostate cancer. Cancer Cells 2, 345–354 (1990).

    CAS  PubMed  Google Scholar 

  10. Kallioniemi, A. et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumours. Science 258, 818–821 (1992).

    Article  CAS  Google Scholar 

  11. Kallioniemi, O.-P. et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumours. Genes Chrom. Cancer 10, 231–243 (1994).

    Article  CAS  Google Scholar 

  12. Lafreniere, R.G. et al. Physical mapping of 60 DNA markers in the p21.1–21.3 region of the human X chromosome. Genomics 11, 352–363 (1991).

    Article  CAS  Google Scholar 

  13. Gaddipati, J.P., McLeod, D.G. & Heidenberg, H.B. Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers. Cancer Res. 54, 2861–2864 (1994).

    CAS  PubMed  Google Scholar 

  14. Kellens, R.E. Gene amplificatlon in mammalian cells. A comprehensive guide. (Marcel Dekker, Inc., New York, 1993).

    Google Scholar 

  15. Nowell, P.C. Mechanisms of tumour progression. Cancer Res. 46, 2203–2207 (1986).

    CAS  PubMed  Google Scholar 

  16. Dennis, L. Role of maximal androgen blockade in advanced prostate cancer. Prostate (suppl) 5, 17–22 (1994).

    Article  Google Scholar 

  17. Crawford, E.D. et al. A controlled trial of leuprolide with and without flutamlde in prostatic carcinoma. New Engl. J. Med. 321, 419–424 (1989).

    Article  CAS  Google Scholar 

  18. Corvi, R., Amler, L.C., Savelyeva, L., Gehring, M. & Schwab, M. MYCN is retained in single copy at chromosome 2 band p23–p24 during amplification in human neuroblastoma cells. Proc. natn. Acad. Sci. U.S.A. 91, 5523–5527 (1994).

    Article  CAS  Google Scholar 

  19. Visakorpi, T. et al. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res. 55, 342–347 (1995).

    CAS  PubMed  Google Scholar 

  20. Cher, M.L., MacGrogan, D., Bookstein, R., Brown, J.A., Jenkins, R.B. & Jensen, R. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chrom. Cancer 11, 153–162 (1994).

    Article  CAS  Google Scholar 

  21. Tanner, M. et al. Increased copy number at 20q13 in breast cancer: defining the minimal region and exclusion of candidate genes. Cancer Res. 54, 2457–2460 (1994).

    Google Scholar 

  22. Sambrook, J., Fritsch, E.F. & Maniatis, T. Molecular Cloning: A Laboratory Manual (Cold Spring Habor Laboratory Press, Cold Spring Harbor, (1989).

    Google Scholar 

  23. Hyytinen, E., Visakorpi, T., Kallioniemi, A., Kallioniemi, O.-P. & Isola, J. Improved technique for analysis of formalin-fixed paraffin-embedded tumours by fluorescence in situ hybridization. Cytometry 16, 93–99 (1994).

    Article  CAS  Google Scholar 

  24. Kallioniemi, O.P. et al. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc. natn. Acad. Sci. U.S.A. 88, 5321–5325 (1992).

    Article  Google Scholar 

  25. Ihalainen, J., Siitari, H., Laine, S., Syvänen, A.C. & Palotie, A. Towards automatic detection of point mutations: use of scintillating microplates in solid-phase minisequencing. Biotechniques 16, 938–943 (1994).

    CAS  PubMed  Google Scholar 

  26. Dixon, W.J. BMDP Statistical Software (University of California Press, Los Angeles, 1981).

    Google Scholar 

  27. Sandberg, A.A. Chromosomal abnormalities and related events in prostate cancer. Hum. Pathol. 23, 368–380 (1992).

    Article  CAS  Google Scholar 

  28. Rinker-Schaeffer, C.W. et al. Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11. Cancer Res. 54, 6249–6256 (1994).

    CAS  PubMed  Google Scholar 

  29. Isaacs, W.B., Bova, G.S., Morton, R.A., Bussemakers, M.J.G., Brooks, J.D. & Ewing, C.M. Molecular biology of prostate cancer. Semin. Oncol. 21, 514–521 (1994).

    CAS  PubMed  Google Scholar 

  30. Macoska, J.A., Micale, M.A., Sakr, W.A., Benson, P.D. & Wolman, S.R. Extensive genetic alterations in prostate cancer revealed by dual PCR and FISH analysis. Genes Chrom. Cancer 8, 88–97 (1993).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Cancer Genetics, Tampere University Hospital and Institute of Medical Technology, P.O. Box 2000, FIN-33521, Tampere, Finland

    Tapio Visakorpi, Eija Hyytinen, Pasi Koivisto, Minna Tanner, Riitta Keinänen, Jorma Isola & Olli-P. Kallioniemi

  2. Laboratory of Cancer Genetics, National Center for Human Genome Research, NIH, Bethesda, Maryland, 20892, USA

    Tapio Visakorpi

  3. Department of Surgery, Division of Urology, Tampere University Hospital,

    Christian Palmberg & Teuvo Tammela

  4. Department of Clinical Sciences, University of Tampere, FIN-33521, Tampere, Finland

    Christian Palmberg & Teuvo Tammela

  5. Department of Clinical Chemistry, Helsinki University Central Hospital, Helsinki, FIN-00290, Finland

    Aarno Palotie

Authors
  1. Tapio Visakorpi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eija Hyytinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pasi Koivisto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Minna Tanner
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Riitta Keinänen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Christian Palmberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Aarno Palotie
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Teuvo Tammela
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jorma Isola
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Olli-P. Kallioniemi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Visakorpi, T., Hyytinen, E., Koivisto, P. et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 9, 401–406 (1995). https://doi.org/10.1038/ng0495-401

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng0495-401

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing